Netarsudil Mesylat/Latanoprost
Brand name: Rocklatan
Rank #238 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$54.7M
Total Cost
103,171
Total Claims
$54.7M
Total Cost
2,397
Prescribers
$531
Cost per Claim
18,860
Beneficiaries
152,975
30-Day Fills
$23K
Avg Cost/Provider
43
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$54.7M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $54.7M total
Top Prescribers of Netarsudil Mesylat/Latanoprost
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Amy Miller | Ophthalmology | Dayton, OH | 727 | $558K |
| 2 | Kundandeep Nagi | Ophthalmology | San Antonio, TX | 734 | $440K |
| 3 | Syed Hasan | Ophthalmology | Dayton, OH | 712 | $416K |
| 4 | Richard Quinones | Ophthalmology | Homewood, IL | 711 | $412K |
| 5 | Frank Moya | Ophthalmology | Winston Salem, NC | 711 | $386K |
| 6 | Triet Nguyen | Ophthalmology | Westminster, CA | 576 | $284K |
| 7 | Alexander Zabaneh | Ophthalmology | Chula Vista, CA | 490 | $271K |
| 8 | Analisa Arosemena | Ophthalmology | Miami Beach, FL | 710 | $270K |
| 9 | Charles Niles | Ophthalmology | Williamsville, NY | 401 | $253K |
| 10 | Adam Reynolds | Ophthalmology | Boise, ID | 341 | $214K |
| 11 | Kim Patel | Optometry | Glendale, AZ | 411 | $198K |
| 12 | Catherine Wang | Ophthalmology | Ocoee, FL | 330 | $192K |
| 13 | Ilona Genis | Ophthalmology | Brooklyn, NY | 484 | $183K |
| 14 | Milton Hearing | Optometry | Palm Springs, FL | 398 | $178K |
| 15 | Randall Stein | Ophthalmology | Mooresville, NC | 355 | $176K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 235 | Exenatide Microspheres (Bydureon Bcise) | $56.6M | 48,670 |
| 236 | Valsartan (Valsartan) | $56.4M | 1,481,937 |
| 237 | Benralizumab (Fasenra Pen) | $54.8M | 9,334 |
| 238 | Netarsudil Mesylat/Latanoprost (Rocklatan) | $54.7M | 103,171 |
| 239 | Amifampridine Phosphate (Firdapse) | $54.4M | 1,203 |
| 240 | Dapaglifloz Propaned/Metformin (Xigduo Xr) | $54.4M | 58,629 |
| 241 | Buspirone Hcl (Buspirone Hcl) | $53.7M | 2,868,147 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology